Published in Am J Physiol on January 01, 1993
High dietary sodium intake impairs endothelium-dependent dilation in healthy salt-resistant humans. J Hypertens (2013) 1.59
Association of sodium and potassium intake with left ventricular mass: coronary artery risk development in young adults. Hypertension (2011) 1.52
Post-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and disease. Mol Cell Proteomics (2015) 1.49
Renal autoregulation in health and disease. Physiol Rev (2015) 1.18
Salt-induced renal injury in SHRs is mediated by AT1 receptor activation. J Hypertens (2011) 0.98
Na+/H+ exchange inhibition attenuates left ventricular remodeling and preserves systolic function in pressure-overloaded hearts. Br J Pharmacol (2004) 0.90
High-salt diet during pregnancy and angiotensin-related cardiac changes. J Hypertens (2010) 0.89
The cardiac renin-angiotensin system is responsible for high-salt diet-induced left ventricular hypertrophy in mice. Eur J Heart Fail (2010) 0.85
NaCl potentiates human fibrocyte differentiation. PLoS One (2012) 0.85
Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction. Ther Adv Cardiovasc Dis (2009) 0.83
The effect of salt on renal damage in eNOS-deficient mice. Hypertens Res (2009) 0.82
Altered expression of Na+ transporters at the mRNA level in rat normal and hypertrophic myocardium. Heart Vessels (2009) 0.80
Effects of kimchi supplementation on blood pressure and cardiac hypertrophy with varying sodium content in spontaneously hypertensive rats. Nutr Res Pract (2012) 0.80
Effects of spironolactone in spontaneously hypertensive adult rats subjected to high salt intake. Clinics (Sao Paulo) (2011) 0.79
Salt, arterial pressure, and cardiovascular and renal damage. Ochsner J (2009) 0.78
High dietary sodium reduces brachial artery flow-mediated dilation in humans with salt-sensitive and salt-resistant blood pressure. J Appl Physiol (1985) (2015) 0.77
Hypertension research program at ochsner: a program in translational research. Ochsner J (2002) 0.76
An updated concept for left ventricular hypertrophy risk in hypertension. Ochsner J (2009) 0.76
Dietary sodium and cardiovascular outcomes: a rational approach. Can J Cardiol (2007) 0.75
Dietary salt restriction in hyperthyroid rats. Differential influence on left and right ventricular mass. Exp Biol Med (Maywood) (2014) 0.75
Isolation of a bacterium that reductively dechlorinates tetrachloroethene to ethene. Science (1997) 7.05
Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol (1998) 5.11
Genomic organization and sequence of T-cell receptor beta-chain constant- and joining-region genes. Nature (1984) 4.15
A third type of murine T-cell receptor gene. Nature (1984) 3.24
Structure, expression and divergence of T-cell receptor beta-chain variable regions. Nature (1984) 2.71
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity (1996) 2.69
Localization of a T-cell receptor diversity-region element. Nature (1984) 1.96
Variability and repertoire size of T-cell receptor V alpha gene segments. Nature (1985) 1.81
Cough associated with the use of captopril. Arch Intern Med (1985) 1.52
A population of murine gammadelta T cells that recognize an inducible MHC class Ib molecule. Science (2000) 1.49
Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med (1999) 1.38
Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol (1980) 1.37
The recognition of the nonclassical major histocompatibility complex (MHC) class I molecule, T10, by the gammadelta T cell, G8. J Exp Med (1997) 1.06
Vasomotor nerve control of isolated arteries and veins. Acta Physiol Scand (1975) 1.05
Issues concerning the nature of antigen recognition by alpha beta and gamma delta T-cell receptors. Immunol Today (1995) 1.03
T cell receptor biochemistry, repertoire selection and general features of TCR and Ig structure. Ciba Found Symp (1997) 1.00
Cardiovascular and sympathetic effects of L-glutamate and glycine injected into the rostral ventrolateral medulla of conscious rats. Hypertens Res (2000) 0.97
Innervation pattern and neurogenic response of rabbit veins. Blood Vessels (1974) 0.94
Topology and affinity of T-cell receptor mediated recognition of peptide-MHC complexes. Curr Opin Immunol (1993) 0.92
Crystal structure of a gammadelta T cell receptor ligand T22: a truncated MHC-like fold. Science (2000) 0.92
Evidence for a functional interaction between the beta chain of major histocompatibility complex class II and the T cell receptor alpha chain during recognition of a bacterial superantigen. J Exp Med (1994) 0.89
Facial vein in the rabbit. Neurogenic vasodilation mediated by beta-adrenergic receptors. Circ Res (1976) 0.88
Family history of hypertension and blood pressure in a screened cohort. Hypertens Res (2001) 0.87
Neuroeffector function of isolated portal vein from spontaneously hypertensive and wistar-kyoto rats: dependence on external calcium concentration. Blood Vessels (1981) 0.87
Changes in left ventricular internal diameter with increasing pericardial pressure. Cardiovasc Res (1975) 0.87
Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats. Cardiovasc Res (1982) 0.82
DOCA-salt induced malignant hypertension in spontaneously hypertensive rats. J Hypertens (1984) 0.82
Role of site of microsphere injection and catheter position on systemic and regional hemodynamics in rat. Am J Physiol (1984) 0.81
Hemodynamic effects of calcitonin gene-related peptide in spontaneously hypertensive rats. Am J Physiol (1990) 0.81
Nitrendipine: hemodynamic effects in conscious normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol (1984) 0.81
Norepinephrine uptake, smooth muscle sensitivity, and metabolizing enzyme activity in rabbit veins. Circ Res (1974) 0.81
Hemodynamic effects of atrial natriuretic hormone. Fed Proc (1986) 0.81
An evaluation of the pericardial sac as a safety factor during tamponade. Cardiovasc Res (1975) 0.80
Brain angiotensin and circulatory control. Clin Exp Pharmacol Physiol (1996) 0.80
Exploratory aspirin resistance trial in healthy Japanese volunteers (J-ART) using platelet aggregation as a measure of thrombogenicity. Pharmacogenomics J (2007) 0.80
Renal response to acute volume overload in conscious rats with atrial appendectomy. J Hypertens (1985) 0.80
Atropine and a hypertensive crisis. Ann Intern Med (1984) 0.80
Left ventricular hypertrophy, cardiac diseases and hypertension: recent experiences. J Am Coll Cardiol (1989) 0.79
Brain angiotensin II contributes to the development of hypertension in Dahl-Iwai salt-sensitive rats. J Hypertens (1995) 0.79
Regression of cardiac hypertrophy and left ventricular pumping ability postregression. J Cardiovasc Pharmacol (1991) 0.79
Systemic and regional hemodynamic effects of acute and prolonged treatment with urapidil or prazosin in normotensive and spontaneously hypertensive rats. Am J Med (1984) 0.78
Short-term effects of angiotensin II blockade on renal blood flow and sympathetic activity in awake rats. Hypertension (1994) 0.78
The role of serotonin in cardiovascular disease. J Cardiovasc Pharmacol (1987) 0.78
[A female case of Fournier's gangrene in a patient with lupus nephritis]. Nihon Jinzo Gakkai Shi (1998) 0.78
Design, synthesis, and biological evaluation of spider toxin (argiotoxin-636) analogs as NMDA receptor antagonists. Pharm Res (1998) 0.78
Reversal of target-organ involvement in systemic hypertension: a pharmacologic experience. Am J Cardiol (1987) 0.78
Change in calcium dependence of isolated arteries after reserpine. Am J Physiol (1969) 0.77
Virus RNA species in kirsten murine sarcoma virus-transformed mink cells. J Gen Virol (1980) 0.77
Multiple risk factor clustering of hypertension in a screened cohort. J Hypertens (2000) 0.77
Atrial extract: hemodynamics in Wistar-Kyoto and spontaneously hypertensive rats. Am J Physiol (1985) 0.77
Analysis of changes in reactivity of rabbit arteries and veins two weeks after induction of hypertension by coarctation of the abdominal aorta. Circ Res (1975) 0.77
Induction of glutathione S-transferases activities in Drosophila melanogaster exposed to phenol. Arch Insect Biochem Physiol (2003) 0.77
Dissociation of changes in cardiovascular mass and performance with angiotensin-converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats. J Am Coll Cardiol (1990) 0.77
Uptake of catamphiphilic drugs into erythrocytes and muscular tissue correlates to membrane enrichment and to 45Ca displacement from phosphatidylserine monolayers. J Pharmacol Exp Ther (1990) 0.77
Atrial natriuretic peptides affect renal metabolism and angiotensin II receptors. Regul Pept Suppl (1985) 0.77
Correction of physiological alterations of hypertension. Cardiovasc Drugs Ther (1987) 0.77
Reduced cardiac mass by nitrendipine is dissociated from systemic or regional haemodynamic changes in rats. Cardiovasc Res (1984) 0.76
Clinical and physiologic significance of local tissue renin-angiotensin systems. Am J Med (1989) 0.76
Renal haemodynamics and comparative effects of captopril in patients with benign- or malignant-essential hypertension, or with chronic renal failure. Clin Exp Hypertens A (1987) 0.76
Kinetic and binding effects of 1,N 6 -ethenoadenosine triphosphate to aspartate transcarbamylase. Biochem Biophys Res Commun (1973) 0.76
Measurement of slowly exchanging 45Ca in rat aorta without using EGTA or lanthanum and its application to quantify the effects of the calcium entry blockers nifedipine and verapamil. Pharmacology (1988) 0.76
Hypotensive and sedative effects of clonidine injected into the rostral ventrolateral medulla of conscious rats. Am J Physiol Regul Integr Comp Physiol (2001) 0.76
Body composition and its relation to systemic haemodynamics, fluid volume partitions and energy utilization in rats with bilateral ventromedial hypothalamic lesions. J Hypertens (1985) 0.76
Immediate and prolonged hemodynamic effects of TA-3090 on spontaneously hypertensive (SHR) and normal Wistar-Kyoto (WKY) rats. Cardiovasc Drugs Ther (1988) 0.76
Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass. Cardiovasc Drugs Ther (1989) 0.76
NPS 1506, a novel NMDA receptor antagonist and neuroprotectant. Review of preclinical and clinical studies. Ann N Y Acad Sci (1999) 0.76
Increased responsiveness of veins to adrenergic stimulation in experimental hypertension. Blood Vessels (1974) 0.76
Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertension man and the spontaneously hypertensive rat. Cardiovasc Drugs Ther (1987) 0.76
Changes in cardiovascular mass, left ventricular pumping ability and aortic distensibility after calcium antagonists in Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens (1992) 0.76
Biologic mechanisms of atrial natriuretic factor. J Lab Clin Med (1987) 0.76
Systemic and regional hemodynamics in normotensive and spontaneously hypertensive rats after slow-channel calcium blocker nitrendipine. Clin Exp Hypertens A (1984) 0.76
Diuretics in hypertension. J Hypertens Suppl (1987) 0.75
ANF does not increase total body venous compliance in conscious rats with myocardial infarction. Am J Physiol (1992) 0.75
Disparate effects of methyldopa and clonidine on cardiac mass and haemodynamics in rats. Clin Sci (Lond) (1980) 0.75
Atriopeptin III does not alter cardiac performance in rats. J Hypertens (1986) 0.75
Quinaprilat increases total body vascular compliance in rats with myocardial infarction. J Cardiovasc Pharmacol (1992) 0.75
Acute pressure increase and intrarenal hemodynamics in conscious WKY and SHR rats. Am J Physiol (1985) 0.75
Hemodynamic and cardiac effects of centrally acting antihypertensive drugs. Hypertension (1984) 0.75
Arterial hypertension after orthotopic cardiac transplantation. J Am Coll Cardiol (1990) 0.75
Hemodynamic studies in spontaneously hypertensive rats with congenital arteriovenous shunts. Am J Physiol (1982) 0.75
Proceedings: Further characteristics of plasmamembraneous calcium binding sites in heart muscle. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
Effects of alpha-receptor inhibition by phentolamine on systemic and regional hemodynamics in spontaneously hypertensive rats. Nihon Jinzo Gakkai Shi (1984) 0.75
Cardiovascular adjustment to antiadrenergic agents. Am J Med (1983) 0.75
Hemodynamic effects of prolonged treatment with diltiazem in conscious normotensive and spontaneously hypertensive rats. Clin Exp Hypertens A (1985) 0.75
Rat platelets activate high molecular weight atrial natriuretic peptides in vitro. Hypertension (1986) 0.75
Changes in the contractile response of arteires and veins from hypertensive rabbits to sympathetic nerve activity: assessment of some postsynaptic influences. Blood Vessels (1976) 0.75
Conversion factors of high- to low-molecular-weight forms of atrial natriuretic factor. Fed Proc (1986) 0.75
Regression of left ventricular hypertrophy in two-kidney, one clip Goldblatt hypertension. Hypertension (1982) 0.75
Hemodynamic effects of a new alpha- and beta-adrenergic receptor inhibitor with calcium entry blocking effects (CGS 10078B) in WKY and SHR rats. Am J Med Sci (1985) 0.75
Hemodynamic responses to bilateral lesions of the nucleus tractus solitarii in spontaneously hypertensive and normotensive rats. Hypertension (1981) 0.75
Systemic and regional hemodynamic changes associated with anterior hypothalamic lesions in conscious rats. Hypertension (1981) 0.75
Calcium antagonists as cardioprotective agents. Am J Cardiol (1992) 0.75
Immediate hemodynamic changes produced by urapidil in normotensive and spontaneously hypertensive rats. Clin Exp Hypertens A (1984) 0.75
Systemic and regional haemodynamics in anterior hypothalamic hypertension in spontaneously hypertensive and Wistar-Kyoto rats. Clin Sci (Lond) (1980) 0.75
Urapidil in normotensive and spontaneously hypertensive rats: the effects on systemic and regional haemodynamics and cardiac mass. J Hypertens (1984) 0.75